While there are limits to what Serhiy and his team can do in clinical trials, they are taking the initiative to help people caught in the war’s crossfire however they can.

A number of MSD’s own employees have been conscripted into the Ukrainian army, including one medically trained colleague who now serves as a doctor near the frontline. The team asked them how they could help, and their colleagues requested an ambulance to help transport wounded soldiers and civilians away from the frontline and into hospitals.

“So we set up a fund, collected money and bought a used ambulance car in Germany, repaired and repainted it and supplied it to the frontline,” said Serhiy. The company has also worked with the $1K Project Ukraine charity (1kproject.org), set up by a Ukrainian married to an MSD research scientist, which sends money directly to Ukrainian families.

“Everyone in Ukraine knows we can’t just rely on the government, we all have to help out,” added Serhiy.

Ukraine’s Plea To Industry: Restart Clinical Trials And Give Us New ‘Weapons’ To Fight Cancer

While Existing Studies Continue, New Trials Have Dried Up

More from Clinical Trials

More from R&D